Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. DiscoverIE Share Price
  4. DiscoverIE Share Regulatory News
  5. Aggreko

Pin to quick picksDiscoverIE Regulatory News (DSCV)

DiscoverIE Information

Share Price Information for DiscoverIE (DSCV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 749.00
Bid: 747.00
Ask: 749.00
Change: 3.00 (0.40%)
Spread: 2.00 (0.268%)
Open: 778.00
High: 778.00
Low: 743.00
Prev. Close: 746.00
DSCV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Aggreko

5 Aug 2021 17:30

RNS Number : 7552H
FTSE Russell
05 August 2021
 

 

 

 

Further to the FTSE Russell notice released on 03 August 2021 in relation to Aggreko (UK): Constituent Deletion, please note the FTSE 250 replacement.

 

All other details remain unchanged. Please see updated notice below:

 

Aggreko (UK): Constituent Deletion - UpdateChanges in FTSE UK Index Series

05 August 2021

Subject to court sanctioning the scheme of arrangement in relation to the cash offer for Aggreko (UK, constituent) by Albion Acquisitions Limited (non constituent), please see details of affected indexes and effective dates below:

 

Aggreko (UK, BK1PTB7) will be deleted from the FTSE 250 Index.

 

Discoverie Group (UK, 0005588) will be added to the FTSE 250 Index and deleted from the FTSE SmallCap Index.

 

All changes are effective from 10 August 2021.

 

Full details of index changes are available on the FTSE Russell website.

 

 

 

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

 

Terms of Use | Copyright © 2021 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSEALPSEDAFEFA
12345678910
Date   Source Headline
18th Apr 20247:00 amRNSFull Year Trading Update
28th Mar 20247:30 amRNSDirector Declaration
22nd Mar 20248:09 amRNSNotification of Major Holdings
20th Mar 20243:45 pmRNSDirector/PDMR Shareholding
14th Mar 20241:21 pmRNSDirector/PDMR Shareholding
19th Feb 20244:07 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSTrading Update
29th Jan 202410:31 amRNSDirector / PDMR Shareholding
8th Jan 20248:41 amRNSNotification of Major Holdings
4th Jan 20244:03 pmRNSNotification of Major Holdings
21st Dec 20233:57 pmRNSNotification of Major Holdings
13th Dec 20239:03 amRNSNotification of Major Holdings
8th Dec 202310:52 amRNSNotification of Major Holdings
5th Dec 20237:00 amRNSInterim Results
22nd Nov 20238:30 amRNSNotice of Interim Results
11th Oct 20237:00 amRNSFirst Half Trading Update
15th Sep 20239:11 amRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSAcquisition of 2J Antennas Group
5th Sep 20232:17 pmRNSNotification of Major Holdings
31st Aug 20237:00 amRNSAcquisition completion - Silvertel
1st Aug 20237:00 amRNSAcquisition of Silvertel
24th Jul 20232:31 pmRNSResults of Annual General Meeting
24th Jul 20237:00 amRNSTrading Update
27th Jun 202310:53 amRNSDirector / PDMR Shareholding
27th Jun 202310:47 amRNSNotification of Major Holdings
22nd Jun 202312:35 pmRNSAnnual Report & Notice of AGM
19th Jun 20238:35 amRNSNotification of Major Holdings
15th Jun 20239:51 amRNSDirector LTIP Award
7th Jun 20237:00 amRNSPreliminary results
1st Jun 20232:50 pmRNSNotification of Major Holdings
30th May 20237:00 amRNSAppointment of Non-Executive Director
18th May 20231:33 pmRNSNotification of Major Holdings
17th May 202310:25 amRNSNotice of Full Year Results
19th Apr 20237:00 amRNSFull Year Trading Update
18th Apr 20237:00 amRNSNotification of Major Holdings
29th Mar 20235:47 pmRNSNotification of Major Holdings
15th Mar 20233:53 pmRNSNotification of Major Holdings
15th Mar 20238:37 amRNSNotification of Major Holdings
15th Mar 20237:00 amRNSNotification of Major Holdings
23rd Feb 20232:58 pmRNSNotification of Major Holdings
20th Feb 20239:48 amRNSNotification of Major Holdings
15th Feb 20235:33 pmRNSNotification of Major Holdings
13th Feb 202311:36 amRNSNotification of Major Holdings
25th Jan 20237:00 amRNSQ3 Trading Update and Acquisition Completion
6th Jan 20231:41 pmRNSNotification of Major Holdings
6th Jan 20238:24 amRNSNotification of Major Holdings
3rd Jan 202310:38 amRNSNotification of Major Holdings
22nd Dec 20227:00 amRNSAcquisition of Magnasphere Corporation
14th Dec 20224:31 pmEQSParadigm Biopharmaceuticals (PAR): Adapted therapies to meet unmet demand
5th Dec 20229:53 amEQSdiscoverIE Group (DSCV): Focused on sustainable growth
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.